© 2020 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Volume 65 No 11: The Technology Issue, November 2020
The November issue of Contemporary OB/GYN is one you do not want to miss.
Novel engineered cytokine plus pembrolizumab to treat ovarian cancer
November 24, 2020
Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.
Women with interstitial lung disease can have safe pregnancies
November 23, 2020
Pregnant women with autoimmune-related interstitial lung disease (ILD) can have safe pregnancy outcomes if closely monitored by a multidisciplinary team of physicians.
First enhanced recovery after surgery guideline for minimally invasive gynecologic surgery
November 23, 2020
The first Enhanced Recovery After Surgery (ERAS) guideline for standardizing and optimizing perioperative care for women undergoing minimally invasive gynecologic surgery (MIGS) has been published in The Journal of Minimally Invasive Gynecology.
This week on Contemporary OB/GYN: November 23 to November 27
November 23, 2020
What to look for this week on Contemporary OB/GYN
COVID-19 Pregnancy Data in the United States: November 19 Update
November 20, 2020
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
Key women’s health and osteoporosis studies you should know about
November 20, 2020
From vitamin D to calcium supplements and beta-blockers for bone loss density prevention, this slideshow from Rheumatology Network breaks it all down.
In case you missed it: Nov. 16 to Nov. 20
November 20, 2020
It was a very busy week for the Contemporary OB/GYN team.
Vitamin K’s impact on bone mineral density and osteoporosis shows mixed results
November 19, 2020
A literature review has concluded that, although some studies find that vitamin K might increase bone mineral density (BMD) and reduce fracture risk in people with osteoporosis, the potential benefits of vitamin K supplements are not sufficiently supported.
FDA approves pembrolizumab for metastatic triple-negative breast cancer
November 19, 2020
Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).
Rising rates of high blood pressure complications in pregnancy
November 19, 2020
An analysis of CDC data presented at American Heart Association's Scientific Sessions 2020 suggests rates of high blood pressure complications during pregnancy nearly doubled during a period lasting from 2008-2017.
S2E7: Surgeons Panel: The state of gynecologic surgery
November 18, 2020
In this episode of Pap Talk, Contemporary OB/GYN Deputy Editor Jon I. Einarsson, MD, MPH, PhD, moderates a discussion with Robert K. Zurawin, MD, and Gaby Moawad, MD, on the new and existing surgical technologies and techniques available in ob/gyn.
How to lead your team through a global pandemic
November 18, 2020
A pandemic has challenged health care leaders like never before. Here’s how to get your team through it.
COVID-19 Pregnancy Data in the United States: November 13 Update
November 17, 2020
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
Maternal COVID-19 infection and placental abnormality
November 17, 2020
Findings from a retrospective study by researchers from NYU suggest that women with COVID-19 in pregnancy have an increased risk of placental abnormalities, regardless of whether their infection is symptomatic.
Share your opinions on shared decision-making
November 17, 2020
Sweeping policy-level implementation efforts have mandated shared decision-making in other areas of medicine; similar mandates could impact ob/gyn.